Novel medicine for migraine

CGRP Antagonists (Gepants):

• Ubrogepant (Ubrelya): Approved for acute treatment; blocks CGRP receptor.

-

New treatment of Migraine

CGRP Antagonists (Small Molecule and Monoclonal Antibodies):

• Small Molecule CGRP Antagonists (Gepants):